Company / Cash & Equivalents
Lunai Bioworks Inc. Cash & Equivalents History
FY2016-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$421.1K
FY2017
5-year range
$421.1K / $421.1K
FY2016-FY2017
Trend
+0.0%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$421,145 in FY2017.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2017, cash & equivalents increased 0.0% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | $421.1K | +0.0% |
| FY2016 | $421.1K | - |
| FY2014 | - | - |
| FY2011 | - | - |
As of FY2017 · SEC 10-K · Updated Jun 24, 2026